Dr. Matthew Budoff
Cardiovascular Disease · Torrance, CA
CMS Profile ID: 127894 · NPI: 1811967433
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$574,074
Number of Payments
406
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $356,082 |
| Consulting Fee | $143,512 |
| Travel and Lodging | $43,156 |
| Honoraria | $19,540 |
| Food and Beverage | $9,284 |
| Education | $2,500 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Novo Nordisk Inc | $99,592 |
| Lilly USA, LLC | $72,135 |
| Lexicon Pharmaceuticals, Inc. | $52,169 |
| Amgen Inc. | $50,232 |
| Regeneron Healthcare Solutions, Inc. | $43,868 |
| Esperion Therapeutics, Inc. | $42,984 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?